TABLE 3 Adverse events of the linezolid therapy group and the control group
Linezolid groupControl groupChi-squaredp-value
Patients n3332
Anaemia17 (51.5)2 (6.3)16.0910.000
Thrombocytopenia4 (12.1)1 (3.1)0.8010.371
Leukopenia5 (15.2)2 (6.3)0.5730.449
Nausea/vomiting16 (48.5)3 (9.4)12.0130.001
Peripheral neuropathy8 (24.2)1 (3.1)4.4320.035
Optic neuropathy6 (18.2)0 (0)4.4240.035
Liver injury6 (18.2)7 (21.9)0.1380.710
Tinnitus or hearing loss4 (12.1)5 (15.6)0.1670.683
Rash or pruritus3 (9.1)3 (9.4)0.0020.968
Arrhythmia3 (9.1)2 (6.3)0.1850.667
Hypokalaemia2 (6.1)2 (6.3)0.0001
  • Data are presented as n (%) unless otherwise stated.